Alan Fuhrman

Chief Financial Officer, ACHIEVE LIFE SCIENCES, INC.

Companies

Tyra Biosciences, Inc.Chief financial officer Jan 3, 2023 to now¹
SpringWorks Therapeutics, Inc.Board member Sep 12, 2019 to now²
Esperion TherapeuticsBoard member Mar 18, 2020 to May 24, 2024³
Checkmate PharmaceuticalsBoard member Aug 6, 2020 to May 31, 2022⁴
Checkmate PharmaceuticalsOfficer Oct 29, 2021 to Oct 29, 2021⁵
SYNLOGIC, INC.Chief financial officer Sep 30, 2015 to Mar 14, 2016⁶
Ambit BiosciencesChief financial officer May 15, 2013 to Nov 12, 2014⁷
ACHIEVE LIFE SCIENCES, INC.Chief financial officer Jan 9, 2006 to Mar 20, 2008⁸

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 15, 2026Granted 951 shares at $9.13 of Tyra Biosciences, Inc.⁹
May 5, 2026Granted 20,000 shares of Tyra Biosciences, Inc.¹²
Mar 13, 2026Granted 1,376 shares at $9.13 of Tyra Biosciences, Inc.¹³
Sep 15, 2025Granted 701 shares at $9.13 of Tyra Biosciences, Inc.¹⁴
Jul 1, 2025Returned to company 24,727 shares of SpringWorks Therapeutics, Inc.¹¹
May 14, 2025Granted 10,060 shares of SpringWorks Therapeutics, Inc.¹⁵
Mar 14, 2025Granted 1,238 shares at $9.78 of Tyra Biosciences, Inc.¹⁶
Oct 30, 2024Bought 9,500 shares at $16.00 of Tyra Biosciences, Inc.¹⁷
Sep 13, 2024Granted 954 shares at $12.48 of Tyra Biosciences, Inc.¹⁸
May 23, 2024Granted 23,000 shares of Esperion Therapeutics¹⁰
May 16, 2024Granted 4,095 shares of SpringWorks Therapeutics, Inc.¹⁹
Mar 15, 2024Granted 932 shares at $12.48 of Tyra Biosciences, Inc.²⁰
Sep 15, 2023Granted 1,463 shares at $12.50 of Tyra Biosciences, Inc.²¹
Jun 15, 2023Granted 5,150 shares of Esperion Therapeutics²²
May 24, 2023Granted 4,648 shares of SpringWorks Therapeutics, Inc.²³
May 19, 2022Granted 4,818 shares of SpringWorks Therapeutics, Inc.²⁴

The numbers on this page point here. Each one links to the record it came from.